Clinical Trials Directory

Trials / Unknown

UnknownNCT05010733

SPECT-CT Metabolic/Morphological Assessment of Cemented Hip Protheses

SPECT-CT Metabolic and Morphological Study of Two Types of Cemented Hip Stem Protheses in Primary Total Hip Arthroplasty Patients: A Randomized Controlled Clinical Trial (SPECT-PROTMA)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Daniel Rodriguez Perez · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Single center, pilot, randomized, controlled clinical trial to assess metabolic and morphological images between two types of cemented stem prostheses in patients undergoing total hip arthroplasty surgery during a 2-year follow up period.

Detailed description

Single center, pilot, controlled clinical trial to assess metabolic and morphological images of patients undergoing total hip arthroplasty surgery randomized to the thick layer technique (Exeter hip stem model) or to the "French paradox" technique (Müller straight stem model). Participants will be performed a plain radiography and a SPECT-CT at 3, 6, 12 and 24 months of the intervention. SPECT-CTs will be performed in addition to the usual medical care complementary imaging exams. The SPECT will require the administration of the 99mTechnetium-methylene diphosphonate (99mTc-MDP) radiopharmaceutical (useful to assess bone metabolism) and its combination with a CT scan (SPECT-CT) allows a combined metabolic and morphological study.

Conditions

Interventions

TypeNameDescription
DEVICETotal hip arthroplasty using the Exeter V40 cemented femoral stemConsists of applying a cement layer of at least 2 millimeters surrounding an undersized prosthetic stem, so that this layer of cement fits between the femoral medullary canal and the prosthetic's femoral stem.
DEVICETotal hip arthroplasty using the Müller Straight StemConsists of applying a thin layer of cement, so that the prosthetic's femoral stem fills as much as possible the femoral medullary canal.

Timeline

Start date
2022-01-01
Primary completion
2023-12-31
Completion
2024-12-31
First posted
2021-08-18
Last updated
2022-03-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05010733. Inclusion in this directory is not an endorsement.